drugset / Trial / NCT00027508
Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ecteinascidin 743 in treating patients who have malignant mesothelioma that cannot be removed by surgery.
Timeline
- Start
- 2001-07
- Primary completion
- 2002-02
- Completion
- 2002-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trabectedin | Small molecule | — | Intravenous |